CD4 and neoplasm: IL17 derived from a subset of CD4+ T helper cells has also been shown to promote anti-tumor immune responses through the recruitment of dendritic cells and cytotoxic cells in several murine tumor models (reviewed in Zou and Restifo, 2010).